Related Experiment Video

Updated: Jan 4, 2026

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.3K

Genetics Helps to Find Synergy for Immune Checkpoint and Targeted Combination Therapies

Ludmila Prokunina-Olsson1

  • 1Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, NCI, NIH, Bethesda, Maryland. prokuninal@mail.nih.gov.

Cancer Research
|November 3, 2019
PubMed

Insights

Checkpoint inhibitors combined with other therapies show promise for ovarian cancer. Targeting ARID1A mutations with histone deacetylase inhibitors and checkpoint blockade may improve patient response.

Area of Science:

  • Oncology
  • Immunotherapy
  • Cancer Genetics

Background:

  • Checkpoint inhibitors like anti-PD-L1 therapy are emerging cancer treatments.
  • Limited response rates necessitate novel therapeutic combinations.
  • Genetic alterations can guide personalized cancer therapy selection.

Purpose of the Study:

  • To investigate a combination therapy for ovarian cancer.
  • To explore the efficacy of targeting ARID1A mutations.

Main Methods:

  • Utilizing a combination of checkpoint inhibitors and histone deacetylase inhibitors.
  • Focusing on ovarian cancer patients with inactivating ARID1A mutations.

Main Results:

  • The study presents a promising approach for ovarian cancer treatment.
  • Combination therapy demonstrated potential synergistic antitumor effects.

Conclusions:

  • Combining immune-based and targeted therapies can improve cancer treatment.
  • Targeting ARID1A mutations with specific inhibitors offers a personalized therapeutic strategy.

More Related Videos

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.7K
High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research09:12

High-Throughput Automated Multiplex Immunofluorescence Assays for Translational Research

Published on: June 10, 2025

948

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K